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Summary  Inﬂammatory  bowel  disease  patients  have  impaired  quality  of  life  with
physical,  social  and  emotional  dysfunction.  This  project  aimed  to  assess  the  effects
of  socio-demographic  and  clinical  variables  on  quality  of  life  and  to  identify  its  pre-
dictors.  In  a  cross-sectional  paper-based  study,  50  consecutive  non-selected  patients
attending  the  teaching  hospital  completed  a  disease-speciﬁc  McMaster  quality  of  life
tool.  Socio-demographic  and  clinical  data  were  collected  from  patients’  records.  The
t-test  and  Mann—Whitney  test  were  used  to  determine  the  probability  of  signiﬁcant
differences  between  quality  of  life  domains  and  independent  variables.  Multiple
linear  regression  was  used  to  determine  quality  of  life  predictors.  Younger  and
highly  educated  patients  had  higher  social  scores.  Those  with  shorter  disease  dura-
tions  had  higher  systemic  scores.  Patients  in  remission  had  higher  systemic,  social,
bowel  and  overall  scores.  Relapse  was  a  signiﬁcant  predictor  of  decreased  systemic,
social,  bowel  and  overall  scores.  Long  disease  duration  was  a  signiﬁcant  predictor  of
decreased  systemic  and  overall  scores.  Younger  age  at  disease  onset  was  a  signiﬁcant
predictor  of  decreased  emotional  score.  However,  high  education  was  a  signiﬁcant
predictor  of  improved  social  score.  Relapse,  long  disease  duration,  low  education
and  young  age  at  disease  onset  were  associated  with  low  quality  of  life.  Prospective
studies  should  investigate  how  interventions  addressing  these  predictors  may  lead
to  improved  quality  of  life.
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Introduction
Inﬂammatory  bowel  disease  (IBD)  refers  to  chronic
inﬂammatory  diseases  of  the  gastrointestinal  tract,
which include  ulcerative  colitis  and  Crohn’s  disease
[1].  IBD  commences  at  any  time,  but  its  highest
incidence occurs  between  15  and  35  years  of  age
[2].
Researchers  have  addressed  the  presentation
and initial  management  of  Arabs  with  IBD  in  Saudi
Arabia  (SA)  [3].
The  pattern  of  the  disease  is  increasing  espe-
cially among  young  Saudi  men  [4,5].
IBD patients  have  impaired  health-related  qual-
ity of  life  (HRQOL)  with  physical,  social  and
emotional dysfunction  [6].
HRQOL tools  provide  subjective  yet  quantita-
tive assessments  of  health  perception  and  function
in the  physical,  social  and  emotional  domains,
which are  distinct  from  measures  of  disease  activ-
ity. HRQOL  tools  can  be  used  to  evaluate  the  natural
history  of  the  disease,  catalogue  the  needs  of  IBD
patients,  focus  the  direction  of  research  and  allo-
cation  of  resources  and  assess  outcome  in  clinical
trials.
Although  generic  measures  of  HRQOL  permit
comparison among  disease  populations,  they  may
be too  imprecise  to  reﬂect  impairment  of  func-
tion in  young  IBD  patients  or  to  gauge  response  to
therapy [7].  Measuring  HRQOL  and  identifying  the
variables affecting  it  is  crucial  for  guiding  profes-
sionals towards  intervention  strategies  tailored  to
improving HRQOL.
In  SA,  most  studies  have  studied  the  incidence
of IBD  and  its  pattern  over  years  [8,9].  This  study
aimed  to  assess  the  effect  of  sociodemographic  and
clinical variables  on  the  HRQOL  of  IBD  patients  and
to identify  predictors  of  QOL.
Materials and methods
This  study  was  conducted  in  the  gastroenter-
ology outpatient  clinic  (OPC)  and  internal  medicine
department  of  a  teaching  hospital  in  Eastern
Province, SA.  It  was  a  cross-sectional  paper  sur-
vey. Fifty  consecutive  non-selected  patients  with
IBD were  enrolled.  Patients  were  recruited  while
receiving  their  treatment  (January—April  2014),
and their  charts  were  retrieved  to  gather  disease-
related data.  Conﬁrmed  IBD  patients  who  were
adults (teenagers  and  above)  and  were  willing  to
participate  were  included.  Patients  with  ileostomy
were excluded.  The  researchers  obtained  the
Arabic-translated  version  of  the  McMaster  short
a
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BD  questionnaire  from  McMaster  University  [10].
Appendix A  for  English  &  B  for  Arabic  version.}
t  is  a disease-speciﬁc,  validated  and  reliable  tool
or measuring  HRQOL  in  adult  patients  with  IBD
nd contains  10  questions.  For  each  question,  there
re graded  responses  on  a  7-point  Likert  scale  ran-
ing from  one  (representing  the  ‘‘worst’’  aspect)
o seven  (representing  the  ‘‘best’’  aspect).  Total
BD questionnaire  (IBDQ)  scores  range  from  10
o 70,  with  higher  scores  reﬂecting  better  well-
eing. Subsequent  validation  of  the  IBDQ  yielded
 strong  correlation  with  disease  severity  (r  =  −0.5;
 <  0.001)  and  a test—retest  reliability  coefﬁcient
f 0.7.  Signiﬁcant  differences  also  occur  between
ctive and  inactive  disease  [10,11]. Patients’  QOL
ata were  collected  through  structured  interviews
y the  study  authors.
Another  data  collection  sheet  collected  demo-
raphic data  (age,  gender,  nationality,  marital
tatus, education  level,  smoking  habits,  etc.)  and
linical data  {disease  duration,  age  at  ﬁrst  diag-
osis of  the  disease  (age  of  onset),  and  disease
ctivity (remission  or  relapse),  method  of  treat-
ent (medical  or  surgical),  etc.}.  Any  surgical
ntervention performed  to  treat  IBD  was  consid-
red surgical  treatment.  However,  patients  under
edical  treatment  did  not  receive  any  surgical
ntervention concerning  IBD  at  all.  Disease  activ-
ty was  classiﬁed  as  relapse  or  remission  based  on
he charts’  documentation.  Physicians  in  the  study
ospital considered  clinical  remission  as  having  no
owel symptoms  associated  with  active  disease,
.e., no  diarrhoea  or  blood  in  stools  and  receiving
o acute  treatment.
SPSS-V20  was  used  for  data  entry  and  analy-
is. Four  QOL  domains  (systemic,  social,  bowel,
nd emotional)  and  SumIBDQ  (SIBDQ)  were  com-
uted for  data  collection  tool  scoring.  The  systemic
omain  was  composed  of  the  sum  of  the  responses
o Q1  and  Q7.  The  social  domain  was  composed
f the  sum  of  the  responses  to  Q2  and  Q3.  The
owel  domain  was  composed  of  the  sum  of  the
esponses to  Q4,  Q6  and  Q9.  The  emotional  domain
as composed  of  the  sum  of  the  responses  to  Q5,
8 and  Q10.  Finally,  SIBDQ  was  composed  of  the
um of  the  responses  to  Q1—Q10.  Mann—Whitney
as used  to  test  the  probability  of  signiﬁcant  differ-
nces between  QOL  domains  and  the  independent
ariables. Multiple  linear  regression  analysis  deter-
ined predictors  of  QOL.  A  p-value  of  ≤0.05  was
ccepted.  The  reliability  and  validity  of  the  QOL
urvey was  tested.
A  pilot  study  was  performed  for  10  patients
fter receiving  formal  approval.  The  data  collec-
ion sheet  was  revised.  Patients  gave  prior  informed
onsent.
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Table  1  Demographic  and  clinical  characteristics  of  Crohn’s  disease  and  ulcerative  colitis  patients  attending  the
teaching  hospital  in  the  Eastern  Province,  SA  (2014).
Characteristics  Crohn’s  disease  Ulcerative  Colitis  Total  p-value
No  (31)  %  No  (19)  %  No  (50)  %
Age  Mean  ±  SD
27.6  ±  11.8
Min  (13)  Max  (61)
Mean  ±  SD
33.9  ±  15.1
Min  (13)  Max  (70)
Mean  ±  SD
29.96  ±  13.53
Min  (13)  Max  (70)
13-  8  25.8  2  10.5  10  20  .130
20-  15  48.4  7  36.8  22  44
30-  8  25.8  10  52.7  18  36
Gender
Male  21  67.7  8  42.1  29  58  .075
Female  10  32.3  11  57.9  21  42
Marital  status
Married  8  25.8  10  52.6  18  36  .073
Single  and  ever  married  23  74.2  9  47.4  32  64
Nationality
Saudi  30  96.8  16  84.2  46  92  .112
Non-Saudi  1  3.2  3  15.8  4  8
Level  of  education
Less  than  secondary  school  4  12.9  7  36.8  11  22  .078
Secondary  school  and  more  27  87.1  12  63.2  39  78
History  of  smoking
Yes  14  45.2  4  21.1  18  36  .085
No  17  54.8  15  78.9  32  64
Place  of  treatment
OPC  2  3.5  5  26.3  7  14  .049*
Inpatient  29  96.5  14  73.7  43  86
Disease  duration  in  years  7.90  ±  6.68
Min  (1)  Max  (26)
9.37  ±  8.80
Min  (1)  Max  (30)
8.46  ±  7.51
Min  (1)  Max  (30)
Less  than  5  16  51.6  9  47.4  25  50  1.000
5  and  more  15  48.4  10  52.6  25  50
Age  at  1st  diagnosis  in  years 19.65  ±  8.90
Min  (9)  Max  (55)
24.00  ±  0.79
Min  (2)  Max  (45)
21.30  ±  9.79
Min  (2)  Max  (55)
Less  than  15  10  32.3  3  15.8  13  26  .320
15-  21  67.7  16  84.2  37  74
Disease  activity
Remission  14  45.2  10  52.6  24  48  .879
Relapse  17  54.8  9  47.4  26  52
Method  of  treatment
Medical  23  74.2  16  84.2  39  78  .407
Surgical  8  25.8  3  15.8  11  22
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(* p value ≤ .05.
esults
he  results  showed  that  the  mean  age  of  the  IBD
atients  was  29.96  ±  13.53.  Forty-four  percent  of
he patients  were  aged  20  to  less  than  30,  and  58%
ere males.  The  majority  were  Saudis  (92%),  and
 high  percentage  had  secondary  school  education
r more  (78%).  The  majority  received  treatment  as
R
C
anpatients  (86%),  and  the  difference  was  signiﬁcant
.049).  A  high  percentage  received  medical  treat-
ent (78%).  More  than  ﬁfty  percent  were  in  relapse
52%) (Table  1).eliability and validity of the QOL survey
ronbach’s  reliability  was  conducted  for  SIBDQ
nd for  each  of  the  four  domains  to  measure  its
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internal  consistency.  Cronbach’s  alpha  values  were
interpreted  using  Richardson’s  suggestions  [12].
Cronbach’s alpha  was  0.859  for  SIBDQ  and  0.252,
0.789,  0.491  and  0.791  for  the  systemic,  social,
bowel  and  emotional  domains,  respectively.  The
Cronbach  alpha  coefﬁcients  for  the  overall  scale
and for  the  social  and  emotional  domains  were
considered high  to  very  high.  The  Cronbach  alpha
coefﬁcient  for  the  bowel  domain  was  average  to
high. The  Cronbach  alpha  coefﬁcient  for  the  sys-
temic  domain  was  present  but  low.
Criterion-related  validity  was  measured  by  cor-
relating SIBDQ  with  each  item  in  each  of  the  four
domains.  For  the  systemic  domain,  there  was  signif-
icant correlation  between  SIBDQ  and  its  two  items
(Spearman  rho’s  R  was  .811  and  .443,  respectively).
For the  social  domain,  there  was  signiﬁcant  corre-
lation between  SIBDQ  and  its  two  items  (Spearman
rho’s R  was  .836  and  .419,  respectively).  Regarding
the bowel  domain,  there  was  signiﬁcant  correla-
tion between  SIBDQ  and  its  two  items  (Spearman
rho’s R  was  .818  and  .860,  respectively).  For  emo-
tional functioning,  there  was  signiﬁcant  correlation
between SIBDQ  and  its  three  items  (Spearman  rho’s
R was  .542,  .515  and  .594,  respectively).  In  addi-
tion, criterion-related  validity  was  measured  by
correlating  SIBDQ  and  the  four  domains.  There
was signiﬁcant  correlation  between  SIBDQ  and  (sys-
temic, social,  bowel  and  emotional)  {Spearman
rho’s R  was  .879,  .879,  .778  and  .762,  respectively}.
This indicated  that  SIBDQ  was  signiﬁcantly  corre-
lated with  the  four  domains  as  well  as  with  each
item for  each  domain.  Accordingly,  the  survey  had
good reliability  and  validity.
Table  2 illustrates  the  mean  scores  of  the  QOL
dimensions as  a  function  of  socio-demographic  and
clinical characteristics.  The  mean  systemic  domain
score showed  a  signiﬁcant  difference  depending  on
disease duration;  patients  who  had  experienced  the
disease for  less  than  5  years  had  better  QOL  scores
than those  who  had  experienced  it  5  years  or  more.
Moreover, the  mean  systemic  domain  score  showed
a signiﬁcant  difference  depending  on  disease  activ-
ity. Patients  in  remission  showed  better  QOL  scores
than those  in  relapse.  The  social  domain  showed
a signiﬁcant  difference  depending  on  patient  age.
Patients  aged  20  years  to  less  than  30  showed  better
QOL scores  than  patients  aged  30  years  or  above.
Moreover,  the  mean  social  domain  score  showed  a
signiﬁcant difference  depending  on  disease  activ-
ity. Patients  in  remission  showed  better  QOL  scores
than those  in  relapse.  The  bowel  domain  showed  a
signiﬁcant difference  depending  on  disease  activity
where  patients  in  remission  had  higher  QOL  scores.
The emotional  domain  did  not  show  a signiﬁcant
difference with  any  independent  variable.  SIBDQ
b
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howed  a signiﬁcant  difference  depending  on  dis-
ase activity  where  patients  in  remission  had  better
OL scores.  Disease  duration  was  nearly  signiﬁ-
ant with  patients  who  had  shorter  disease  duration
howing  better  QOL  scores.
Table  3  presents  predictors  of  QOL  domains.  The
ariance  in  the  QOL  score  of  the  systemic  domain
ue to  these  independent  variables  was  29.7%  (R
quare = .297)  and  the  overall  regression  was  sig-
iﬁcant (p  value  =  .003).  Change  in  disease  activity
nd duration  was  signiﬁcantly  negatively  associ-
ted with  change  in  QOL  score.  Relapse  resulted
n a  decrease  in  QOL  score  of  2.186.  Moreover,  an
ncrease  in  disease  duration  was  associated  with
 decrease  in  QOL  score  of  2.109.  For  the  social
omain, the  variance  in  the  QOL  score  was  26.7%
R square  =  .267),  and  the  overall  regression  was  sig-
iﬁcant (p  value  = .006).  A  change  in  disease  activity
as signiﬁcantly  negatively  associated  with  change
n QOL  score.  Relapse  resulted  in  a decrease  in
OL score  of  2.296.  However,  QOL  score  was  statis-
ically positively  associated  with  education  level.
aving higher  education  was  associated  with  an
ncrease in  QOL  score  of  1.728.  Regarding  bowel
unctioning,  the  variance  in  the  QOL  score  was
2.9%  (R  square  = .329)  and  the  overall  regression
as signiﬁcant  (p  value  =  .006).  A  change  in  disease
ctivity was  signiﬁcantly  negatively  associated  with
 change  in  QOL  score.  Again,  relapse  resulted  in  a
ecrease in  the  QOL  score  of  3.486.  For  emotional
unctioning, the  variance  in  the  QOL  score  was
7.7%  (R  square  = .177),  and  the  overall  regression
as not  signiﬁcant.  However,  age  at  ﬁrst  diag-
osis was  statistically  negatively  associated  with
OL score.  Young  age  at onset  was  associated  with
 decrease  in QOL  score  of  2.866.  Finally,  the
ariance in  the  QOL  score  of  SIBDQ  represented
8.8% (R  square  = .288),  and  the  overall  regression
as signiﬁcant  (p  =  .009).  QOL  score  was  statisti-
ally  negatively  associated  with  disease  activity  and
isease duration  in  years.  Relapse  resulted  in  a
ecrease  in  QOL  score  of  11.341,  and  long  disease
uration  was  associated  with  a  decrease  in  QOL
core of  8.163.
iscussion
ecently  the  importance  of HRQOL  in  chronic  dis-
ases has  been  increasingly  recognized  because  of
ts implications  for  patients’  psychological  well-
eing, social  adjustment  to  the  illness,  and  use
f health  resources  [13]. Measuring  HRQL  provides
mportant  data  to  quantify  the  impact  of  disease  on
he daily  life  of  patients  [14].
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Table  2  Means  of  QOL  dimensions  as  a  function  of  socio-demographic  and  clinical  characteristics  in  the  univariate
analysis  of  IBD  patients  attending  the  teaching  hospital  in  the  Eastern  Province,  SA  (2014).
Type  of  the  disease  Systemic  Social  Bowel  Emotional  SIBDQ
Mean  rank  Mean  rank  Mean  rank  Mean  rank  Mean  ±  SD
Crohn’s  disease 25.94  27.40  24.37  23.65  44.38  ±  11.87
Ulcerative  Colitis 24.79  22.39  27.34  28.53 45.46  ±  12.97
Age  p-value  .029*
20-  23.07  24.07  21.93  21.95  47.46  ±  12.58
30-  17.36  16.14  18.75  18.72  41.95  ±  11.45
Gender
Male  26.07  27.21  27.62  26.66  46.18  ±  11.63
Female  24.71  23.14  22.57  23.90  42.86  ±  12.81
Marital  Status
Married  24.47  23.58  24.47  25.08  45.16  ±  13.31
Single  and  ever  married  26.08  26.58  26.08  25.73  44.12  ±  9.99
Nationality
Saudi  26.45  26.20  26.08  25.43  45.22  ±  12.39
Non-Saudi  14.63  17.50  18.88  26.25  39.82  ±  7.94
Level  of  education  p-value  .046*
Less  than  secondary  school  23.00  17.91  19.95  27.41  41.40  ±  13.00
Secondary  school  and  more  26.21  27.64  27.06  24.96  45.74  ±  11.87
History  of  smoking
Yes 25.44  26.14  28.31  23.50  44.97  ±  11.52
No  25.53  25.14  23.92  26.63  44.69  ±  12.64
Place  of  treatment
OPC  21.93  25.43  22.07  27.79  43.14  ±  13.46
Inpatient  26.08  25.51  26.06  25.13  45.06  ±  12.05
Disease  duration  in  years  p-value  .022* p-value  .091
Less  than  5  30.20  28.22  26.96  27.96  47.69  ±  11.80
5  and  more  20.80  22.78  24.04  23.04  41.89  ±  11.97
Age  at  1st  diagnosis  in  years
Less  than  15  22.58  24.00  23.15  29.62  44.67  ±  13.00
15-  26.53  26.03  26.32  24.05  44.83  ±  11.99
Disease  activity  p-value  .009* p-value  .006* p-value  .001* p-value  .007*
Remission  31.30  31.57  32.59  26.35  49.65  ±  9.69
Relapse  20.56  20.33  19.46  24.78  40.64  ±  12.61
Method  of  treatment
Medical  26.32  26.38  26.38  26.23  45.65  ±  12.25
Surgical  22.59  22.36  22.36  22.91  41.73  ±  11.71
i
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h* p-value ≤ .05.
Both  clinicians  and  researchers  emphasize  the
mportance  of  integrating  HRQOL  into  the  assess-
ent of  chronic  disease  outcomes  and  the  impact
f interventions  [15].
The relationship  between  socio-demographic
nd  clinical  factors  and  patient  HRQOL  has  been
nvestigated  [16—18].  The  majority  of  studies  have
ndicated  the  importance  of  age,  educational  level
16—19]  or  sex  [18]  with  regard  to  HRQOL  in  IBD
rocesses.  The  present  study  showed  that  patients
ged 20  years  to  less  than  30  years  and  patients
e
l
Hith  higher  education  levels  had  signiﬁcantly  better
ocial QOL  scores  (Table  2).  This  could  be  because
ndividuals at  this  age  had  engagement  that  was
ore social.
In addition,  patients  at  this  age  are  more  inter-
sted in  doing  leisure/sport  activities.  Similarly,  for
ighly educated  patients,  they  may  be  more  knowl-
dgeable  about  the  importance  of  participating  in
eisure/sport  activities.
Female  gender  was  associated  with  a lower
RQOL [18,20]. López  et  al.,  2005  found  that  men
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Table  3  Multiple  linear  regression  model  testing  for  the  predictors  of  quality  of  life  of  IBD  patients  attending  the
teaching  hospital  in  the  Eastern  Province,  SA  (2014).
Variable  ˇ  St  error  T  p-value  R-Square  F  p
Systemic  domain  .297  4.753  .003
Relapse −2.186 .646  −3.383  .001*
Long  disease  duration −2.109 .722 −2.182 .005*
Level  of  education .232 .762 .305 .762
Age  in  years  .197  .499  .394  .696
Social  domain  .267  4.101  .006
Relapse  −2.296  .737  −3.116  .003*
High  education  level  1.728  .869  1.987  .05*
Disease  duration  in  years  −1.045  .823  −1.269  .211
Age  in  years  −.090  .569  −.159  .875
Bowel  functioning  .329  3.515  .006
Relapse  −3.486  .929  −3.753  .001*
Level  of  education  2.009  1.167  1.721  .092
Type  of  IBD  1.787  1.059  1.687  .099
Disease  duration  in  years  −.951  1.055  −.902  .372
Age  in  years  −.809  .769  −1.053  .298
Place  of  treatment 1.472  1.341  1.097  .279
Emotional  functioning  .177  1.892  .115
Young  age  of  onset  −2.866  1.308  −2.191  .034*
Type  of  IBD  2.152  1.185  1.817  .076
Disease  duration  in  years  −2.013  1.110  −1.813  .077
Gender  −1.459  1.157  −1.260  .214
Disease  activity  −1.017  1.131  −.899  .373
SIBDQ  .288  3.561  .009
Relapse  −11.341  3.196  −3.549  .001*
Long  disease  duration  −8.163  3.135  −2.604  .013*
Age  at  1st  diagnosis  −3.935  3.694  −1.065  .293
Type  of  IBD  2.993  3.345  .895  .276
Gender  −4.549  3.269  −1.391  .171
r
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s* p-value ≤ .05.
showed  higher  QOL  scores  in  systemic,  bowel,  emo-
tional and  social  symptoms  and  global  IBDQ,  and  the
differences  were  signiﬁcant  [14]. However,  gender
did not  affect  any  QOL  domain  in  the  current  study.
Other  studies  concluded  that  demographic
parameters  did  not  signiﬁcantly  affect  IBDQ-D
scores [21].
The  duration  of  IBD,  the  effects  of  treatments,
and the  consequences  of  its  complications  (e.g.,
hospitalizations)  affect  the  daily  lives  of  these
patients and  impair  their  HRQOL  [19]. Our  results
demonstrated  that  longer  disease  duration  (5  years
or more)  was  associated  with  signiﬁcantly  lower  sys-
temic QOL  scores  than  shorter  duration  (less  than
5 years)  {Table  2}.  This  may  be  because  patients
experienced many  symptoms,  complications  and
consequences  of  therapy  over  time  that  resulted
in decreased  systemic  QOL  scores.
The clinical  course  of  the  disease  is charac-
terized by  unpredictable  periods  of  relapse  and
(
n
a
femission  in  spite  of  conventional  therapies.  Many
atients do  not  maintain  a durable  remission  [22].
isease activity  is  one  of  the  most  important  factors
or decreased  HRQOL  [23]. Patients  with  relapse
ad signiﬁcantly  more  disease-related  worries  and
oncerns, more  impaired  social  functioning  and  a
educed feeling  of  well-being.  Patients  in  relapse
ad greater  concerns,  more  impairment  of  func-
ional status  and  a  reduced  subjective  sense  of
ell-being  relative  to  those  in  clinical  remission
24]. IBD  patients  in  remission  scored  signiﬁcantly
igher QOL  scores  for  all  domains  using  Short  Form-
6 [25]. Patients  in  relapse  had  statistically  lower
cores than  those  in  remission  for  SIBDQ  and  the
ystemic,  social  and  bowel  domains  (Table  2).
Clinical variables  such  as  type  of  treatment
medical treatment  or  surgery),  therapy  effective-
ess, occurrence  of  extra  intestinal  symptoms,
nnual rate  of  ﬂare-ups,  their  severity  or  the  need
or hospitalization  have  an  impact  on  IBD  patients’
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Dssessment  of  health-related  quality  of  life  
RQL  [26].  Moreover,  Lopez  et  al.,  2005  [14]  showed
hat patients  undergoing  surgery  had  lower  global
RQL scores  in  comparison  to  those  who  received
edical treatment,  and  the  difference  was  signif-
cant.  This  contradicts  the  present  study  where
here was  no  signiﬁcant  difference  depending  on
ethod,  place  of  treatment  or  age  at  ﬁrst  diagnosis
ith any  QOL  domain.
Crohn’s  disease  patients  were  more  affected  by
heir disease  in  terms  of  HRQOL  than  patients  with
lcerative  colitis  [19,27].  Other  studies  found  that
iagnosis did  not  inﬂuence  any  of  the  IBDQ  dimen-
ions  [25,27].  In  this  study,  the  type  of  disease  did
ot affect  any  of  the  QOL  domains  nor  the  SIBDQ.
his ﬁnding  is  in  line  with  the  work  of  Lopez  et  al.
2005),  where  IBDQ  scores  were  similar  for  both
iseases  [14].
Identifying  the  factors  associated  with  HRQL  is
elevant  because  it  may  allow  clinicians  to  modify
ome of  them,  thereby  improving  patients’  health
14].
redictors of HRQOL
nderstanding  predictors  of  HRQOL  may  facilitate
nterventions to  improve  HRQOL  and  overall  IBD
anagement  [20].
Variables  related  to  disease  activity,  such  as  the
resence  of  relapse,  were  the  most  important  vari-
ble for  predicting  HRQOL  [25].  The  present  study
howed  that  relapse  was  a  signiﬁcant  predictor  for
he systemic,  social  and  bowel  domains,  as  well  as
IBDQ. Relapse  resulted  in  a  decrease  of  QOL  scores
Table  3).
Disease  duration  was  a  signiﬁcant  predictor  for
ystemic  and  SIBDQ  scores  where  longer  disease
uration led  to  a  decrease  of  QOL  scores  (Table  3).
his ﬁnding  could  be  ascribed  to  troublesome  com-
lications  of  steroid  therapy  or  experiencing  more
elapses  over  time.
This  is comparable  with  another  study  as  there
as a  signiﬁcant  effect  for  disease  duration  show-
ng that  those  patients  with  short  disease  duration
ad lower  HRQOL  scores  compared  with  patients
ith long  disease  duration  [28]. This  result  was
xplained by  the  disease  having  a  tendency  to  be
ore active  in  the  ﬁrst  course  or  by  the  patient
ot yet  receiving  the  most  adequate  treatment.
nother study  found  no  report  on  differences  in
RQOL in  patients  with  either  short  or  long  history
f IBD.
In  this  study,  no  difference  was  found  in  HRQOL
mong the  three  groups  of  patients  concerning  dis-
ase duration:  less  than  one  year,  between  one  and
ve years  and  more  than  ﬁve  years  [29].
C
N
p99
Young  age  at  onset  (less  than  15  years)  was  a
igniﬁcant predictor  for  emotional  QOL  (Table  3).
t contributed  17.7%  to  the  variance  in  emotional
unctioning. This  could  be  because  young  patients
ere not  able  to  cope  with  the  disease,  relapse  or
omplications  of  therapy.
However,  the  literature  revealed  that  when
hese lifelong  illnesses  are  diagnosed  during  ado-
escence,  a critical  developmental  period,  the
ransition  to  adulthood  could  be  even  more  turbu-
ent. IBD  patients  are  at  risk  for  depression,  anxiety,
ocial isolation  and  altered  self-image,  which  can
ll negatively  affect  HRQOL  [30].
Prospective  studies  should  investigate  how  inter-
entions  addressing  these  factors  may  lead  to
mproved  HRQOL.
Higher  education  level  led  to  improvement  in
ocial QOL  scores  (Table  3). This  is  because  edu-
ated  patients  may  have  more  chance  to  read  more
bout the  disease  and  learn  how  to  cope  with  fre-
uent relapses.  Moreover,  educated  patients  may
how higher  adherence  to  treatment  therapy.  Edu-
ation may  improve  the  coping  skills  of  patients
ith chronic  diseases  [31]. Education  results  in  less
n-patient care,  fewer  visits  to  primary  care  physi-
ians, improved  treatment  adherence,  decreased
nxiety and  enhanced  quality  of  life.  Patients  with
elatively high  levels  of  disease-related  knowledge
re those  with  higher  educational  attainment  and
hose receiving  information  through  the  internet
32].
As the  assessment  of  disease  activity  was  based
n physicians’  opinions  as  documented  in  patients’
harts,  this  was  considered  a  limitation  of  our  study.
onclusions
elapse,  long  disease  duration  (≥5  years),  low  edu-
ation and  young  age  at  disease  onset  (patients  less
han 15  years  of  age)  may  entail  increased  risk  for
ecreased  HRQOL.
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